Shares of drug maker Ranbaxy Laboratories tumbled nearly 6 per cent in early trade on Bombay Stock Exchange (BSE) after reporting a disappointing set third quarter numbers ended September 30.
The pharma major has reported a consolidated net loss of Rs 454 crore for the third quarter ended September 2013 (Q3) due to forex loss.
Weighed down by numbers, shares of the company declined as much as 5.63 per cent to trade at Rs 363.90 a piece on the BSE.
In a similar fashion, shares of the company slipped 2.17 per cent to Rs 374.95 a piece on National Stock Exchange.
Meanwhile, the broader benchmark Sensex was quoting at 20,991.21, up 62.20 points or 0.30 per cent at 10:05 hours.